February 21, 2012 ·
Leave a comment
Industry Insights from Paul Meade, M. Sc., MPH
While the Mayans might have been good at developing a cosmic calendar with 27,000-year cycles, I will try to venture only one or two years out and predict some developments within the healthcare system.
I dare say the Mayans had great foresight about changes, even if they never invented the wheel, but clearly they missed the fact that 2012 was an election year in the United States, and that predicting change became no mean task with orders of magnitude of difficulty. Nonetheless, I will attempt to gaze into my crystal ball and give my predictions for the next little while.
The promise of personalized medicine has been swirling around in the minds of brilliant people for well over a decade now, but we are patiently awaiting the results to impact our daily lives. Throughout the past 10-15 years, advances in the personalized medicine field have been somewhat slow to appear on the landscape. We should not be too discouraged by this advancing timeline, since we are still waiting for a cure for cancer after many decades of highly-funded research. Yet, each day, scientists are discovering more and more biomarkers with the potential to move us closer the reality of personalized medicine.
These biomarkers are not only predicting diseases—they are identifying companion diagnostics, indicating response levels to ... read more »
TAGS: 
Accountable Care Organizations biomarkers biotechnology companion diagnostics healthcare healthcare delivery Healthcare Professionals medicine Paul Meade personalized medicine pharmaceuticals predictive medicine public health research and development Thought Leader Select US healthcare reform US healthcare system
June 2, 2010 ·
Leave a comment
Paul Meade, a 25-year veteran of the pharmaceutical industry, founded Thought Leader Select in 2006. Throughout his career, Paul served in several leadership positions in sales, marketing, and strategic planning, culminating in his role of director of worldwide commercial development for predictive medicine at GlaxoSmithKline.
After leaving GSK, Paul launched two companies, Clear Point Health, in 2005, and Thought Leader Select, in 2006. Paul’s work with these two companies entails marketing planning, consulting for research and development and clinical operations, as well as his breakthrough work with medical expert collaborations for the pharmaceutical industry.
The Thought Leader Select Blog sat down with Paul to discuss his industry experience and his professional contribution to Thought Leader Select.
TLS Blog: Good afternoon, Paul. Why did you start Thought Leader Select?
Paul Meade: About a year before starting the company, I had begun consulting with the health industry with my partner, Lisa Smith, through our company, Clear Point Health. We were taking on a number of projects, working with medical affairs teams, marketing teams, and research and development groups within the industry.
One of our large clients came to me and told me that, even though they’d been working with thought leaders for over ten years, they realized how little they really knew about them. When they sat down to consolidate all of their knowledge about their medical ... read more »
TAGS: advisory boards biotechnology Civil Air Patrol Clear Point Health clinical operations clinical research clinical trials commercial development committees Gillings School for Global Public Health GlaxoSmithKline Johns Hopkins University key opinion leaders KOL engagement KOL identification KOL profiling KOLs marketing planning master of public health medical ethics medical experts Merck Paul Meade pharmaceutical pharmaceutical marketing pharmaceutical sales predictive medicine public health publishing research and development research methodology The Immortal Life of Henrietta Lacks Thought Leader Select thought leaders transparency United States Air Force University of North Carolina at Chapel Hill
May 11, 2010 ·
Leave a comment
May 11, 2010 (CHAPEL HILL, NC) Paul Meade, founder and president of Thought Leader Select, a North Carolina firm dedicated to key opinion leader (KOL) development solutions for the biopharmaceutical industry, received a master of public health degree from the University of North Carolina at Chapel Hill on May 8, 2010.
The Gillings School of Global Public Health at UNC awarded Meade, a 25-year veteran of the pharmaceutical industry, with a master of public health degree and a certificate in public health ethics in the Public Health Leadership Program. Meade’s research report, “How Volunteer Community Organizations Can Assist State Public Health Departments During Pandemic Influenza,” explored specific possibilities for the Civil Air Patrol, a volunteer non-profit national organization and an auxiliary of the United States Air Force, to assist state public health officials during widespread outbreaks of influenza.
The master of public health degree is Meade’s second master’s degree. He earned a master of science in biomedical science from the University of Guelph (Canada) in 1977, following his bachelor of science degree in biology and chemistry from Acadia University (Canada) in 1971.
During his 25-year career in the pharmaceutical industry, Meade served in a variety of leadership positions at Merck and GlaxoSmithKline. During his ten years at Merck, Meade worked his way from a sales representative position to director of marketing planning for ... read more »
TAGS: biopharmaceutical biotechnology certificate Civil Air Patrol Clear Point Health clinical operations clinical researchers Gillings School of Global Public Health GlaxoSmithKline healthcare ethics healthcare policy healthcare research key opinion leaders KOL deployment KOL development KOL engagement KOL identification KOL profiling KOLs marketing planning master of public health medical affairs Merck nurses Paul Meade pharmaceutical pharmacists physician assistants physicians predictive medicine public health ethics Public Health Leadership Program research and development Thought Leader Select United States Air Force University of North Carolina at Chapel Hill veterinarians
